论文部分内容阅读
目的探讨头孢哌酮钠舒巴坦钠和阿奇霉素联合治疗老年社区获得性肺炎的临床效果。方法选取2013年1月至2013年12月期间在我院接受治疗的老年社区获得性肺炎患者60例,并将其随机分为观察组与对照组。对照组患者以头孢哌酮钠舒巴坦钠进行治疗,观察组患者在此基础上联合阿奇霉素进行治疗,对两组患者的治疗效果进行观察比较。结果观察组患者的治疗有效率及细菌清除率分别为90.0%及88.0%;对照组患者的治疗有效率及细菌清除率分别为76.7%及70.3%。两组数据存在显著差异,结果具有统计意义(p<0.05)。结论头孢哌酮钠舒巴坦钠联合阿奇霉素治疗老年社区获得性肺炎具有较好的临床效果,该种治疗方法值得在临床上广泛推广,以帮助更多患者受益。
Objective To investigate the clinical efficacy of cefoperazone sodium and sulbactam combined with azithromycin in the treatment of elderly community-acquired pneumonia. Methods Sixty elderly community-acquired pneumonia patients treated in our hospital from January 2013 to December 2013 were selected and randomly divided into observation group and control group. Patients in the control group were treated with cefoperazone sodium and sulbactam sodium. Patients in the observation group were treated with azithromycin on the basis of the above treatment, and the therapeutic effect was compared between the two groups. Results The effective rate of treatment and the rate of bacterial eradication in the observation group were 90.0% and 88.0% respectively. The effective rate of treatment and bacterial clearance in the control group were 76.7% and 70.3%, respectively. Significant differences between the two groups of data, the results were statistically significant (p <0.05). Conclusion Cefoperazone sodium and sulbactam sodium combined azithromycin in the treatment of elderly community-acquired pneumonia has a good clinical effect, the treatment is worthy of widespread clinical application to help more patients benefit.